240 related articles for article (PubMed ID: 12460192)
1. Induction of 4-1BB (CD137) expression by DNA damaging agents in human T lymphocytes.
Kim KM; Kim HW; Kim JO; Baek KM; Kim JG; Kang CY
Immunology; 2002 Dec; 107(4):472-9. PubMed ID: 12460192
[TBL] [Abstract][Full Text] [Related]
2. NF-kappaB and AP-1 regulate activation-dependent CD137 (4-1BB) expression in T cells.
Kim JO; Kim HW; Baek KM; Kang CY
FEBS Lett; 2003 Apr; 541(1-3):163-70. PubMed ID: 12706838
[TBL] [Abstract][Full Text] [Related]
3. Enhanced CD4 T cell responsiveness in the absence of 4-1BB.
Lee SW; Vella AT; Kwon BS; Croft M
J Immunol; 2005 Jun; 174(11):6803-8. PubMed ID: 15905521
[TBL] [Abstract][Full Text] [Related]
4. Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue, and its possible role in tumor immunity.
Wan YL; Zheng SS; Zhao ZC; Li MW; Jia CK; Zhang H
World J Gastroenterol; 2004 Jan; 10(2):195-9. PubMed ID: 14716821
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells.
Futagawa T; Akiba H; Kodama T; Takeda K; Hosoda Y; Yagita H; Okumura K
Int Immunol; 2002 Mar; 14(3):275-86. PubMed ID: 11867564
[TBL] [Abstract][Full Text] [Related]
6. Molecular and biological characterization of human 4-1BB and its ligand.
Alderson MR; Smith CA; Tough TW; Davis-Smith T; Armitage RJ; Falk B; Roux E; Baker E; Sutherland GR; Din WS
Eur J Immunol; 1994 Sep; 24(9):2219-27. PubMed ID: 8088337
[TBL] [Abstract][Full Text] [Related]
7. CD137 and CD137 ligand constitutively coexpressed on human T and B leukemia cells signal proliferation and survival.
Palma C; Binaschi M; Bigioni M; Maggi CA; Goso C
Int J Cancer; 2004 Jan; 108(3):390-8. PubMed ID: 14648705
[TBL] [Abstract][Full Text] [Related]
8. Functional expression of 4-1BB (CD137) in the inflammatory tissue in Crohn's disease.
Maerten P; Geboes K; De Hertogh G; Shen C; Cadot P; Bullens DM; Van Assche G; Penninckx F; Rutgeerts P; Ceuppens JL
Clin Immunol; 2004 Sep; 112(3):239-46. PubMed ID: 15308117
[TBL] [Abstract][Full Text] [Related]
9. Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy.
Li Q; Carr A; Ito F; Teitz-Tennenbaum S; Chang AE
Cancer Res; 2003 May; 63(10):2546-52. PubMed ID: 12750278
[TBL] [Abstract][Full Text] [Related]
10. Constitutive expression of 4-1BB on T cells enhances CD4+ T cell responses.
Kim J; Choi SP; La S; Seo JS; Kim KK; Nam SH; Kwon B
Exp Mol Med; 2003 Dec; 35(6):509-17. PubMed ID: 14749528
[TBL] [Abstract][Full Text] [Related]
11. Activation of c-jun N-terminal kinase by 4-1BB (CD137), a T cell co-stimulatory molecule.
Kim HH; Kwack K; Lee ZH
Mol Cells; 2000 Jun; 10(3):247-52. PubMed ID: 10901161
[TBL] [Abstract][Full Text] [Related]
12. Costimulation of T cells by OX40, 4-1BB, and CD27.
Croft M
Cytokine Growth Factor Rev; 2003; 14(3-4):265-73. PubMed ID: 12787564
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells.
Salih HR; Kosowski SG; Haluska VF; Starling GC; Loo DT; Lee F; Aruffo AA; Trail PA; Kiener PA
J Immunol; 2000 Sep; 165(5):2903-10. PubMed ID: 10946324
[TBL] [Abstract][Full Text] [Related]
14. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses.
Shuford WW; Klussman K; Tritchler DD; Loo DT; Chalupny J; Siadak AW; Brown TJ; Emswiler J; Raecho H; Larsen CP; Pearson TC; Ledbetter JA; Aruffo A; Mittler RS
J Exp Med; 1997 Jul; 186(1):47-55. PubMed ID: 9206996
[TBL] [Abstract][Full Text] [Related]
15. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
Heinisch IV; Bizer C; Volgger W; Simon HU
J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and immunological characteristics of 4-1BB (CD137) receptor and ligand and potential applications in cancer therapy.
Sica G; Chen L
Arch Immunol Ther Exp (Warsz); 1999; 47(5):275-9. PubMed ID: 10604232
[TBL] [Abstract][Full Text] [Related]
17. Expression of 4-1BB molecule on peripheral blood T cells in liver transplanted patients and its clinical implication.
Wan YL; Zheng SS; Jia CK; Liang TB; Huang DS; Wang WL; Li MW; Zhao ZC
Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):38-43. PubMed ID: 14599927
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human homologue of 4-1BB and its ligand.
Zhou Z; Kim S; Hurtado J; Lee ZH; Kim KK; Pollok KE; Kwon BS
Immunol Lett; 1995 Feb; 45(1-2):67-73. PubMed ID: 7622190
[TBL] [Abstract][Full Text] [Related]
19. Immunity in the absence of CD28 and CD137 (4-1BB) molecules.
Vinay DS; Wolisi GO; Yu KY; Choi BK; Kwon BS
Immunol Cell Biol; 2003 Jun; 81(3):176-84. PubMed ID: 12752681
[TBL] [Abstract][Full Text] [Related]
20. Role of the stress kinase pathway in signaling via the T cell costimulatory receptor 4-1BB.
Cannons JL; Hoeflich KP; Woodgett JR; Watts TH
J Immunol; 1999 Sep; 163(6):2990-8. PubMed ID: 10477561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
